Loading…
avatar for Susan Rosencrance

Susan Rosencrance

FDA, United States
Director, Office of Lifecycle Drug Products, OPQ, CDER
Dr. Susan Rosencrance presently heads FDA's Office of Lifecycle Drug Products within the Office of Pharmaceutical Quality (OPQ). She provides executive leadership by overseeing and directing scientific review programs and activities related to evaluating drug product quality throughout the lifecycle (brand to generic). Susan has a long history with the FDA working in various roles within CDER. Prior to joining the Agency she worked at Merck's R&D labs in a new drug discovery program. She holds a Ph.D. in Chemistry from American University and completed her dissertation research in the Laboratory of Biophysical Chemistry at the National Institutes of Health (NIH).
  • Timezone
  • Filter By Date DIA 2021 Virtual Global Annual Meeting Jun 1 -Jul 1, 2021
    • June 2021
      SunMonTueWedThuFriSat
       12345
      6789101112
      13141516171819
      20212223242526
      27282930 
      July 2021
      SunMonTueWedThuFriSat
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
  • Filter By Venue Virtual Meeting
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Featured Topics